27317610|t|Diffuse traumatic brain injury affects chronic corticosterone function in the rat
27317610|a|As many as 20-55% of patients with a history of traumatic brain injury (TBI) experience chronic endocrine dysfunction, leading to impaired quality of life, impaired rehabilitation efforts and lowered life expectancy. Endocrine dysfunction after TBI is thought to result from acceleration - deceleration forces to the brain within the skull, creating enduring hypothalamic and pituitary neuropathology, and subsequent hypothalamic -pituitary endocrine (HPE) dysfunction. These experiments were designed to test the hypothesis that a single diffuse TBI results in chronic dysfunction of corticosterone (CORT), a glucocorticoid released in response to stress and testosterone. We used a rodent model of diffuse TBI induced by midline fluid percussion injury (mFPI). At 2 months postinjury compared with uninjured control animals, circulating levels of CORT were evaluated at rest, under restraint stress and in response to dexamethasone, a synthetic glucocorticoid commonly used to test HPE axis regulation. Testosterone was evaluated at rest. Further, we assessed changes in injury - induced neuron morphology (Golgi stain), neuropathology (silver stain) and activated astrocytes (GFAP) in the paraventricular nucleus (PVN) of the hypothalamus. Resting plasma CORT levels were decreased at 2 months postinjury and there was a blunted CORT increase in response to restraint induced stress. No changes in testosterone were measured. These changes in CORT were observed concomitantly with altered complexity of neuron processes in the PVN over time, devoid of neuropathology or astrocytosis. Results provide evidence that a single moderate diffuse TBI leads to changes in CORT function, which can contribute to the persistence of symptoms related to endocrine dysfunction. Future experiments aim to evaluate additional HP-related hormones and endocrine circuit pathology following diffuse TBI.
27317610	0	30	Diffuse traumatic brain injury	T037	UMLS:C2832047
27317610	47	61	corticosterone	T103	UMLS:C0010124
27317610	78	81	rat	T204	UMLS:C0034721
27317610	119	126	history	T033	UMLS:C0332119
27317610	130	152	traumatic brain injury	T037	UMLS:C0876926
27317610	154	157	TBI	T037	UMLS:C0876926
27317610	274	297	lowered life expectancy	T033	UMLS:C1504437
27317610	327	330	TBI	T037	UMLS:C0876926
27317610	399	404	brain	T017	UMLS:C0006104
27317610	416	421	skull	T017	UMLS:C2951888
27317610	441	453	hypothalamic	T017	UMLS:C0020663
27317610	458	467	pituitary	T017	UMLS:C0032005
27317610	468	482	neuropathology	T038	UMLS:C1540677
27317610	499	511	hypothalamic	T017	UMLS:C0020663
27317610	499	532	hypothalamic -pituitary endocrine	T022	UMLS:C0014136
27317610	534	537	HPE	T022	UMLS:C0014136
27317610	539	550	dysfunction	T038	UMLS:C0277785
27317610	558	569	experiments	T062	UMLS:C0681814
27317610	621	632	diffuse TBI	T037	UMLS:C2832047
27317610	652	663	dysfunction	T038	UMLS:C0277785
27317610	667	681	corticosterone	T103	UMLS:C0010124
27317610	683	687	CORT	T103	UMLS:C0010124
27317610	692	706	glucocorticoid	T103	UMLS:C0017710
27317610	731	737	stress	T038	UMLS:C0449430
27317610	742	754	testosterone	T103	UMLS:C0039601
27317610	766	778	rodent model	T038	UMLS:C1519106
27317610	782	793	diffuse TBI	T037	UMLS:C2832047
27317610	805	836	midline fluid percussion injury	T037	UMLS:C3714660
27317610	838	842	mFPI	T037	UMLS:C3714660
27317610	882	907	uninjured control animals	T204	UMLS:C1511501
27317610	931	935	CORT	T103	UMLS:C0010124
27317610	966	982	restraint stress	T038	UMLS:C0449430
27317610	1002	1015	dexamethasone	T103	UMLS:C0011777
27317610	1019	1043	synthetic glucocorticoid	T103	UMLS:C0017711
27317610	1066	1069	HPE	T022	UMLS:C0014136
27317610	1070	1074	axis	T082	UMLS:C1522496
27317610	1075	1085	regulation	T038	UMLS:C1327622
27317610	1087	1099	Testosterone	T103	UMLS:C0039601
27317610	1155	1161	injury	T037	UMLS:C3714660
27317610	1172	1178	neuron	T017	UMLS:C0027882
27317610	1191	1202	Golgi stain	T058	UMLS:C0487602
27317610	1205	1219	neuropathology	T038	UMLS:C1540677
27317610	1221	1233	silver stain	T058	UMLS:C0487602
27317610	1239	1248	activated	T038	UMLS:C1326120
27317610	1249	1259	astrocytes	T017	UMLS:C0004112
27317610	1261	1265	GFAP	T058	UMLS:C0487602
27317610	1274	1297	paraventricular nucleus	T017	UMLS:C0030532
27317610	1299	1302	PVN	T017	UMLS:C0030532
27317610	1311	1323	hypothalamus	T017	UMLS:C0020663
27317610	1333	1339	plasma	T031	UMLS:C0032105
27317610	1340	1344	CORT	T103	UMLS:C0010124
27317610	1414	1418	CORT	T103	UMLS:C0010124
27317610	1443	1467	restraint induced stress	T038	UMLS:C0449430
27317610	1469	1479	No changes	T033	UMLS:C0442739
27317610	1483	1495	testosterone	T103	UMLS:C0039601
27317610	1528	1532	CORT	T103	UMLS:C0010124
27317610	1588	1594	neuron	T017	UMLS:C0027882
27317610	1595	1604	processes	T038	UMLS:C0007613
27317610	1612	1615	PVN	T017	UMLS:C0030532
27317610	1637	1651	neuropathology	T038	UMLS:C1540677
27317610	1655	1667	astrocytosis	T038	UMLS:C3887640
27317610	1717	1728	diffuse TBI	T037	UMLS:C2832047
27317610	1749	1753	CORT	T103	UMLS:C0010124
27317610	1857	1868	experiments	T062	UMLS:C0681814
27317610	1896	1915	HP-related hormones	T103	UMLS:C0019932
27317610	1920	1929	endocrine	T022	UMLS:C0014136
27317610	1958	1969	diffuse TBI	T037	UMLS:C2832047